Pig Interleukin 10 (IL10) Protein

Este producto es parte de IL10 - Interleukin 10
Product Graph
338€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Pig Interleukin 10 (IL10) Protein
category
Proteins and Peptides
provider
Abbexa
reference
abx670317
tested applications
ELISA, WB

Description

Pig Interleukin 10 (IL10) Protein is a Recombinant protein expressed in Pichia pastoris.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Proteins and Peptides
Immunogen Target
Interleukin 10 (IL10)
Host
Yeast
Recommended Dilution
Optimal dilutions/concentrations should be determined by the end user.
Origin
Pig
Conjugation
Unconjugated
Size 1
5 µg
Form
Lyophilized 
Tested Applications
ELISA, WB
Buffer
Prior to lyophilization: Phosphate buffered saline
Availability
Shipped within 3-7 working days.
Storage
Store at 4 °C for up to one week. For long-term storage, store at -20 °C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
Q29055
Alias
CSIF,GVHDS,IL-10,IL10A,TGIF,Cytokine synthesis inhibitory factor
Background
Protein IL10
Status
RUO
Note
This product is for research use only.   Not for human consumption, cosmetic, therapeutic or diagnostic use.

Descripción

IL10 is an anti-inflammatory cytokine produced by macrophages, T regulatory cells, and other immune cells to suppress excessive immune responses and maintain tissue homeostasis IL10 signaling occurs through the IL-10 receptor (IL10R) and activates the JAK/STAT3 pathway, inhibiting the production of pro-inflammatory cytokines such as TNF-α, IL1β, and IL6 It plays a pivotal role in immune tolerance, limiting damage caused by chronic inflammation and infections Dysregulation of IL10 expression is associated with autoimmune diseases, such as Crohn's disease, multiple sclerosis, and psoriasis IL10 also exerts immunosuppressive effects in the tumor microenvironment, facilitating tumor progression and immune evasion due to its inhibitory influence on T cells and antigen-presenting cells IL10-based therapies are being explored for managing inflammatory diseases and promoting immune modulation in cancer and chronic infections

Related Products

EB0075

Bovine IL-10(Interleukin 10) ELISA Kit

Ver Producto
ECA0012

Canine IL-10(Interleukin 10) ELISA Kit

Ver Producto
ECH0033

Chicken IL-10(Interleukin-10) ELISA Kit

Ver Producto